Loading...
Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis
OBJECTIVE: The association between the use of renin–angiotensin–aldosterone (RAAS) inhibitors and the risk of mortality from COVID-19 is unclear. We aimed to estimate the association of RAAS inhibitors, including ACE inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) with COVID-19 mortali...
Na minha lista:
| Udgivet i: | Open Heart |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7646321/ https://ncbi.nlm.nih.gov/pubmed/33154144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2020-001353 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|